Other languages Aker BioMarine

Equities

AKBM

NO0010886625

Market Closed - Oslo Bors Other stock markets 08:15:00 26/04/2024 pm IST			5-day change	1st Jan Change
71.3 ^NOK	-1.79%		+0.56%	+55.00%

26/04	Aker BioMarine AS Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/04	Transcript : Aker BioMarine AS, Q1 2024 Earnings Call, Apr 26, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aker BioMarine AS Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Aker BioMarine AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/02
Aker BioMarine AS Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
Aker BioMarine ASA Receives Purchase Order for Algae-Based Omega-3 Oils	08/12
Aker BioMarine Wins $6 Million Order for Omega-3 Oils; Production Capacity Expansion Planned	08/12
Aker BioMarine AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	01/11
Aker BioMarine Gains Krill Assets from Acasti Pharma in $3.1 Million Settlement Deal	24/23/24
Aker Biomarine Begins Krill Oil Sales in South Korea	25/23/25
Aker Biomarine Announces Successful Launch of Superba Krill Oil in South Korea	25/23/25
Aker BioMarine's Krill Oil Brand Wins Australian Nod for Two Health Claims	25/23/25
Aker BioMarine Gains Regulatory Approval for US Commercial Launch of Dietary Supplement	10/23/10
Aker BioMarine ASA Receives Approval for LYSOVETA as New Dietary Suppient in the US	10/23/10
Aker BioMarine AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14
Aker BioMarine AS Provides Revenue Guidance for the Full Year of 2023	14/23/14
Aker BioMarine Spinoff, Microsoft Norway Team Up on Plastic Circularity	02/23/02
Aker BioMarine AS Provides Sales Guidance for the Second Quarter of 2023	28/23/28
Aker BioMarine AS Reports Earnings Results for the First Quarter Ended March 31, 2023	31/23/31
Aker BioMarine AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	15/23/15
Aker BioMarine AS Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15
Aker BioMarine ASA Announces Ministry of Food and Drug Safety in South Korea Approves Superba Krill Oil	21/22/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aker BioMarine

Equities

AKBM

NO0010886625

Other languages

Filters